Studies On Efficacy And Safety Of Glibenclamide And PioglitazoneDrugs In Type 11 Non- Insulin Depende -Nt Diabetes Mellitus Patients

Authors: Ghulam Rasool Bhurgri, Hussain Bux Korijo, Muhammad Ali Qureshi,

MUHAMMAD MEDICAL COLLEGE
MUHAMMAD MEDICAL COLLEGE
MUHAMMAD MEDICAL COLLEGE

Volume 16 | Issue 3

Published: November 10, 2026

Abstract

To evaluate the efficacy and safety of Glibenclamide and Pioglitazone drugs
in type 11 non- insulin dependent diabetes mellitus patients. STUDY DESIGN: study was prospective, randomized study. PLACE AND DURATION: This study was conducted in the department of Pharmacololgy and Therapeutics, Muhammad Medical College Mirpurkhas, in collaboration with Medical Outpatient Department of Civil Hospital Dadu, Sindh PATIENTS, METHOD: Hundred and twenty NIDDM (type-II) diabetic patients were enrolled in the study from the out patient department civil hospital Dadu. All the patients were divided in two groups. RESULTS: In fasting blood sugar, the mean values of glibenclamide group at the start, six months were 150.5 ±22.0, 92.2 ±10.7 respectively, while that of Pioglitazone group were 150.5 ± 22.0, 101.7± 5.4 respectively. Therefore, the mean reduction of two hours postprandial blood glucose from the start till the end of the study (in 6th months) in glibenclamide group was 92.2 ±10.7 and pioglitazone was 101.7± 5.4. . Therefore, the mean reduction of HbA1c in the whole study in glibenclamide group was was6.6 ± .9 and pioglitazone group was7.4 ± .92 .All variables showed significant (P-value >0.05) when we compared between base line and 6 months study time period. In case of safety of drugs in glibenclamide 4.7% and pioglitazone 12% reactions were observed in the study. CONCLUSION: In the light of this study it is obvious that glibenclamide was more effective, tolerable and safer than pioglitazone in a short duration of therapy.

Keywords: Diabetes mellitus, Non-insulin diabetes mellitus, Insulin dependent diabetes mellitus, Glibenclamide, Pioglitazone, Insulin.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF